RESPIRA THERAPEUTICS
Live / Registered — Registered (as of 10 Aug 2021)
What this means for you
Registered since 10 Aug 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 10 Aug 2027, and its filing window is open now).
Record
- Serial number
- 87516804
- Registration number
- 6449036
- Mark type
- Design + words
- Filed
- 05 Jul 2017
- Published for opposition
- 22 May 2018
- Registered
- 10 Aug 2021
- Next maintenance filing
- §8 declaration of use, due by 10 Aug 2027 (grace period to 10 Feb 2028)
- Attorney of record
- Ben Natter
Goods and services
- Class 005 — Pharmaceuticals: Inhaled pharmaceuticals administrated by aerosols delivered to patients via oral inhalation comprising therapeutics or diagnostic agents for the treatment or prophylaxis of local lung and/or systemic diseases
Owner
- Respira Therapeutics, Inc., Albuquerque, NM, US
- Respira Therapeutics, Inc., Albuquerque, NM, US
- Respira Therapeutics, Inc., Albuquerque, NM, US
Board proceedings on this mark
The owner also pleads this mark in 2 other Board proceedings.
Prosecution history
- 10 Aug 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 20 Jan 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Jan 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Jan 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 27 Oct 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 27 Oct 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Oct 2021 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 27 Oct 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 Oct 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 27 Oct 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 10 Aug 2021 — REGISTERED-PRINCIPAL REGISTER
- 07 Jul 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Jul 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Jun 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Jun 2021 — USE AMENDMENT FILED